Journal of Neuro-Oncology

, Volume 56, Issue 2, pp 109–117 | Cite as

Mitogen Activated Protein Kinase Activation and Oxidant Signaling in Astrocytoma Cells

  • Poonam A. Kuruganti
  • Robert D. Wurster
  • Pamela A. Lucchesi


Presence of increased reactive oxygen species (ROS) has been observed in most high risk factors for brain tumor development. Our past study demonstrated that ROS could induce increased brain tumor cell proliferation. Growth effects of ROS may involve modifications of cellular proteins such as mitogen-activated protein kinases (MAPKs), which regulate cell proliferation. Here, we report effects of a ROS (hydrogen peroxide, H2O2) and an antioxidant (N-acetylcysteine, NAC) on MAPK activation in astrocytoma (U373-MG) cells. MAPKs are activated by phosphorylation that can be detected by Western blot analysis. The unphosphorylated/inactivated form of MAPK exhibits slower mobility on SDS-PAGE compared to the phosphorylated/activated form. Densitometric analysis was used to measure MAPK activation. Results indicate that H2O2 caused a dose and time-dependent increase in MAPK activation in astrocytoma cells. Furthermore, ROS-induced activation was almost completely suppressed by NAC. NAC also inhibited serum-induced MAPK activation indicating there may be an oxidant-sensitive component to serum-induced growth signaling. Modifications of MAPKs by H2O2 demonstrate that ROS-induced proliferation is via biochemical pathways similar to other known growth stimuli. Understanding of processes that link a proliferation signal (ROS) to cell proliferation can aid in the selection of therapy used to suppress brain tumor growth.

oxidative stress brain tumor MAP kinase tumor promoter antioxidant signal transduction 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sun Y: Free radicals, antioxidant enzymes, and carcinogenesis. Free Rad Biol Med 8: 377-408, 1989Google Scholar
  2. 2.
    Remacle J, Raes M, Toussaint O, Renard P, Rao G: Low levels of reactive oxygen species as modulators of cell function. Mutation Res 316: 103-122, 1995Google Scholar
  3. 3.
    Warren BS, Slaga TJ: Mechanisms of inhibition of tumor progression. Basic Life Sci 61: 279-89, 1993Google Scholar
  4. 4.
    Frei B: Natural Antioxidants in Human Health and Disease. San Diego, Academic Press, 1994Google Scholar
  5. 5.
    Bongers V, de Jong J, Steen I, de Vries N, Bast A, Snow GB, Braakhuis BJM: Antioxidant-related parameters in patients treated for cancer chemoprevention with N-acetylcysteine. Eur J Cancer 31A: 921-923, 1995Google Scholar
  6. 6.
    Arora-Kuruganti P, Lucchessi PA, Wurster RD: Proliferation of cultured human astrocytoma cells response to an oxidant and antioxidant. J Neuro-Oncol 44(3): 213-221, 1999Google Scholar
  7. 7.
    Chen Q, Olashaw N, Wu J: Participation of reactive oxygen species in the lysophosphatidic acid-stimulated mitogen-activated protien kinase kinase activation pathway. J Biol Chem 270: 28499-28502, 1995Google Scholar
  8. 8.
    Brumell JH, Burkhardt AL, Bolen JB, Grinstein S: Endogenous reactive oxygen intermediates activate tyrosine kinases in human neutrophils. J Biol Chem 271: 1455-1461, 1996Google Scholar
  9. 9.
    Goldstone SD, Hunt NH: Redox regulation of the mitogen-activated protein kinase pathway during lymphocyte activation. Biochim Biophys Acta 1355: 353-360, 1997Google Scholar
  10. 10.
    Cobb MH, Hepler JE, Cheng M, Robbins D: The mitogen-activated protein kinases, ERK1 and ERK2. Sems Cancer Biol 5: 261-268, 1994Google Scholar
  11. 11.
    Graves JD, Campbell JS, Krebs EG: Protein serine/threonine kinases of the MAPK cascade. Annals N Y Acad Sciences 766: 320-343, 1995Google Scholar
  12. 12.
    Guan KL: The mitogen-activated proten kinase signal transduction pathway: from the cell surface to the nucleus. Cell Signal 6: 581-589, 1994Google Scholar
  13. 13.
    Stevenson MA, Pollock SS, Coleman CN, Calderwood SK: X-irradiation, phorbol esters, and H2O2 stimulate mitogen-activated protein kinase activity in NIH-3T3 cells through the formation of reactive oxygen intermediates. Cancer Res 54: 12-15, 1994Google Scholar
  14. 14.
    Mordet G: MAP kinase kinase: a node connecting multiple pathways. Biol Cell 193-207, 1993Google Scholar
  15. 15.
    Szatrowski TP, Nathan CF: Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51: 794-798, 1991Google Scholar
  16. 16.
    Carmine TC, Bruchelt G, Hahn T, Niethammer D: Measurement of endogenous and TNFα-mediated H2O2 production in supernatents of SK-N-SH neuroblastoma cells with an enhanced chemiluminescence. J Biolumin Chemilumin 9: 267-272, 1994Google Scholar
  17. 17.
    Carter WO, Narayanan PK, Robinson JP: Intracellular hydrogen peroxide and superoxide detection in endothelial cells. J Leukocyte Biol 55: 253-258, 1994Google Scholar
  18. 18.
    Gopalakrishna R, Chen ZH, Gundimeda U: Modifications of cysteine-rich regions in protein kinase C induced by oxidant tumor promoters and enzyme-specific inhibitors. Methods in Enzymol 252: 132-146, 1995Google Scholar
  19. 19.
    Schwartz JL, Antoniades DZ, Zhao S: Molecular and biochemical reprogramming of oncogenesis through the activity of prooxidants and antioxidants. Annals N Y Acad Sciences 23: 262-285, 1993Google Scholar
  20. 20.
    Sozer O, Voller K, Liyanage M, Frith D, Kour G, Stabel S: Activation of c-raf by protein kinase C phosphorylation. Oncogene 7: 2259-2262, 1992Google Scholar
  21. 21.
    Chakraborti S, Chakraborti T: Down-regulation of protein kinase C attenuates the oxidant hydrogen peroxide-mediated activation of phospholipase A2 in pulmonary vascular smooth muscle cells. Cell Signal 7: 75-83, 1995Google Scholar
  22. 22.
    Rao G: Protein tyrosine kinase activity is required for oxidant-induced extracelluloar signal-regulated protein kinase activation and c-fos and c-jun expression. Cell Signal 9: 181-187, 1997Google Scholar
  23. 23.
    Oude Weernik PA, Verheul E, Kerkhof E, Van Veelen CW, Rijksen G: Inhibitors of protein tyrosine phosphorylation reduce the proliferation of two human glioma cell lines. Neurosurgery 38(1): 108-13; discussion 113-114, 1996Google Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • Poonam A. Kuruganti
    • 1
  • Robert D. Wurster
    • 2
  • Pamela A. Lucchesi
    • 3
  1. 1.Neuroscience ProgramLoyola University Chicago, Stritch School of MedicineMaywoodUSA
  2. 2.Neuroscience Program; Department of Physiology; Department of Neurological SurgeryLoyola University Chicago, Stritch School of MedicineMaywoodUSA
  3. 3.Department of PhysiologyLoyola University Chicago, Stritch School of MedicineMaywoodUSA

Personalised recommendations